Australia looks to speed clinical trial start-up times

By Zachary Brennan

- Last updated on GMT

Australia looks to speed clinical trial start-up times
Australia’s National Health and Medical Research Council (NHMRC) is getting pragmatic with increasingly long clinical trial timelines and is now looking to streamline the research governance process in order to reduce delays in trial commencement.

More specifically, the council has released a Good Practice Process​ to streamline the site assessment and site authorization of trials. According to the NHMRC, two key improvements that will reduce the time taken to begin trials have been proposed by the council’s development group:

  • An increased commitment to planning, preparation and ongoing support for clinical trials within institutions where trials are conducted; and
  • A change to the order in which the activities within the assessment and authorization process are conducted, whereby key assessment activities occur much earlier.

Pharma companies, clinical researchers and CROs (contract research organizations) have raised concerns about the length of time taken to commence clinical trials in Australia, and particularly about the time taken to complete research governance, the council says.

The proposed order in which activities can be completed in the Good Practice Process represents a paradigm shift from the way in which the site assessment and authorisation process has traditionally been conducted​,” the NHMRC says.

The new guidance offers three main differences between the proposed process and previous methodology:

  • The majority of site assessment activities can be conducted not just at the same time as, but prior to, ethical reviews being undertaken;
  • Many of these activities can be conducted in parallel instead of sequentially; and
  • Some key site assessment activities can be substantively completed in the feasibility assessment stage and then formalized in documentation rather than be delayed until all documentation is submitted.

Related news

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Related suppliers

Follow us

Products

View more

Webinars